Clinical Trial Update: Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updating a Phase 1/2 study of liposomal curcumin with radiotherapy and temozolomide for newly diagnosed glioblastoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Liposomal Curcumin (curcumin liposomal formulation)
• Temozolomide (Temozolomide)

Snippet

Sponsor: SignPath Pharma, Inc. | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING